Pancreatic Cancer Research

ResearcherJohannes Kepler University of LinzActive in the last 2 years

Holger F. Rumpold

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4118-0111; OpenAlex author ID A5050587597, A5109439213. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 3 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Understanding Genomic Instability Score in Platinum-Treated Advanced Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm15197632↗
  2. NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data. Co-author DOI 10.1016/j.esmoop.2025.105827↗
  3. Data of 'Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage'. Co-author DOI 10.1016/j.dib.2022.107944↗
  4. Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage. Co-author DOI 10.1016/j.ejso.2021.11.138↗
  5. Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer. Last author DOI 10.3389/fonc.2022.902177↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Patrick Kirchweger · 5 shared papers, 2022–2026 · strength 0.90
  2. Andreas Reichinger · 2 shared papers, 2025–2026 · strength 0.46
  3. Bernhard Doleschal · 2 shared papers, 2025–2026 · strength 0.46
  4. Helwig Wundsam · 3 shared papers, 2022 · strength 0.44
  5. R. Függer · 2 shared papers, 2022 · strength 0.29
  6. Florian Primavesi · 1 shared paper, 2026 · strength 0.24
  7. Justus Leinhos · 1 shared paper, 2026 · strength 0.24
  8. Hossein Taghizadeh · 1 shared paper, 2025 · strength 0.22
  9. Gerald W. Prager · 1 shared paper, 2025 · strength 0.22
  10. Matthias Biebl · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.